Is Intensity Therapeutics, Inc. (INTS) a Buy, Sell, or Hold?
NASDAQ : INTS
Intensity Therapeutics, Inc. — Analyst Ratings
$4.16 USD
-$0.09 (-2.13%)
- Volume
- 22.34K
- Average Volume
- 40.36K
- Market Capitalization
- $11.24M
- P/E Ratio
- -0.60
- Dividend Yield
- 0.00%
- Price Target
- $125.00
- Year High
- $43.50
- Year Low
- $3.51
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.86
Analyst Consensus Summary
Consensus Rating
Sell
3 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-96.7%
vs Current Price
Price Target
$125.00
Average TargetPrice Target Range
Lowest Target
$125.00
-96.7% DOWNSIDE
Average Target
$125.00
Median Estimate
Highest Target
$125.00
-96.7% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 3
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 3 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Swayampakula Ramakanth | $5 | $76.25 | 2024-10-31 02:04 AM | -93.4% |